卵巢癌患者在明确诊断时多数已属晚期或较晚期，对这些患者用单一的治疗方式是不够的。即便是I期患者，有些属高危者，在手术以后也应采用化疗或其他辅助治疗。当今出疗已成为卵巢癌的重要治疗手段。化疗适应证的掌握，药物的选择及方案的组合等对疗效会起很大作用。本文将对手 Ovarian cancer patients with a clear majority of the diagnosis is late or late, for these patients with a single treatment is not enough. Even in patients with stage I, some are at risk, after surgery should also be used chemotherapy or other adjuvant therapy. Today’s treatment has become an important treatment for ovarian cancer. Chemotherapy indications of mastery, the choice of drugs and the combination of programs will play a significant role in the curative effect. This article will rival